Search AI Products and News

Alibaba's AI model, DAMO PANDA, has recently received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This achievement marks a significant breakthrough in early pancreatic cancer screening, offering new possibilities for early diagnosis. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model focused on pancreatic cancer screening. Its primary function is to analyze plain CT images and accurately identify subtle lesions that are difficult for the human eye to detect.

The health tech sector has seen significant funding recently, highlighting the rapid rise and widespread adoption of artificial intelligence in healthcare. Early-stage venture capital firm SignalFire secured $1 billion in funding to support AI-focused startups. This brings SignalFire's total assets under management to $3 billion, underscoring its prominence in the industry. SignalFire's portfolio includes several healthcare startups, such as Grow.

Alibaba's AI model, DAMO PANDA, has been officially designated a breakthrough medical device by the U.S. Food and Drug Administration (FDA). This certification marks a significant breakthrough for Alibaba in the field of AI-powered healthcare and represents the first time a leading Chinese tech company has received this prestigious recognition. DAMO PANDA, developed by Alibaba's DAMO Academy, is an AI model designed for pancreatic cancer screening. It aims to accurately identify subtle lesions in CT images, aiding in early detection of the disease.

Microsoft co-founder Bill Gates recently offered insightful perspectives on AI's impact on work. Gates argues that work isn't an inherent human purpose, but a product of scarcity, fundamentally relying on human intelligence to provide diverse services. He envisions an AI revolution transforming traditional industries within a decade. In healthcare and education, AI systems are projected to handle over 80% of routine diagnoses, drug development, and knowledge dissemination. AI's precise algorithms and continuous operation enable it to not only...

With the rapid development of artificial intelligence technology, internet healthcare platforms are accelerating the integration of large model AI to improve service efficiency and user experience. Ark Health (06086.HK), led by Xie Fangmin, indicates that after years of observation, up to 80% of medical consultations involve repetitive questions, wasting patients' time and increasing the workload of doctors. Against this backdrop, the call for using AI technology to reduce the burden on doctors is growing stronger. In early 2023, the popularity of DeepSeek triggered...

In the healthcare sector, artificial intelligence (AI) is becoming an attractive solution to enhance efficiency in clinical, research, and administrative tasks. Recently, healthcare technology startup Qventus successfully completed a $105 million Series D funding round, further solidifying its position in the AI healthcare field. This round was led by KKR and included $85 million in equity financing and $20 million in optional debt. Qventus's CEO and co-founder Mudit G...

Globally, public healthcare systems face numerous challenges in the aftermath of the pandemic, particularly under the increasing pressure of an aging population in Western countries. The UK’s National Health Service (NHS) crisis often makes headlines. In this context, more private enterprises are recognizing market opportunities. Cera, a UK company focused on home healthcare services, has recently secured $150 million in funding, with a majority in debt. Although the company has not disclosed specific valuation and funding structure details, this round of financing was led by BDT & MSD.

In the aftermath of the pandemic, the healthcare restart efforts are facing significant challenges, particularly in the context of an aging population in Western countries. Public healthcare systems are under immense pressure, with the UK's National Health Service (NHS) frequently in crisis and making headlines. In this environment, many private companies, especially tech-driven enterprises, have identified substantial gaps in the healthcare service market. Against this backdrop, the UK-based proprietary software platform and home healthcare provider Cera has announced it has raised $150 million through debt and equity financing to further expand its operations.

Recently, Brazilian startup Carecode announced the successful completion of a $4.3 million pre-seed funding round. This funding will be used to develop its AI-based customer service system. The project aims to enhance customer experience in the healthcare industry, helping hospitals and medical institutions communicate more efficiently with patients. With the rapid advancement of AI technology, Carecode's innovative services are expected to play a significant role in the healthcare sector. Image source note: The image is AI-generated and licensed by Midjourney.

As the potential of artificial intelligence in healthcare draws increasing attention, Brazilian startup Carecode is emerging in this trend. Carecode focuses on leveraging AI agents to handle various tasks before and after medical appointments, aiming to lower healthcare costs and improve outcomes. CEO Thomaz Srougi stated in an interview that the importance of not only face-to-face meetings with doctors cannot be overlooked, but also the stages before and after appointments are crucial. His medical background stems from a decade of industry experience, during which he founded.

MRI images have long been a significant challenge in medical imaging analysis due to their complexity and large data volume. To train large language models (LLMs) for MRI analysis, developers have had to slice the captured images into 2D images. While this approach is feasible, it limits the model's ability to analyze complex anatomical structures, particularly in intricate cases such as brain tumors, skeletal diseases, or cardiovascular conditions. Image source note: Image generated by AI, licensed by Midjourney. However, GE Healthcare this year...

The application of artificial intelligence in healthcare has reached a major breakthrough! A study conducted by several top institutions, including Harvard University and Stanford University, shows that OpenAI's o1-preview model demonstrates astonishing capabilities in multiple medical reasoning tasks, even surpassing human doctors. This research not only evaluated the model's performance on medical multiple-choice question benchmarks but also focused on its diagnostic and management capabilities in simulated real clinical scenarios, yielding impressive results. Researchers conducted five experiments to assess o1-

Healthcare AI company Suki announced that it has successfully raised $70 million in new funding. This funding will be used for the development of its products, including an AI-driven voice assistant designed for clinical practitioners. Caption note: Image generated by AI, image licensed from provider Midjourney. Suki's founder and CEO Punit Soni stated, "The demand for AI in the healthcare industry is growing, and we are proud to offer a fully functional solution that seamlessly interoperates with existing tools."

The expert team formed by the MIFA Laboratory of the Shanghai Jiao Tong University Qingtuan Research Institute and the Endocrinology Department of Zhongshan Hospital affiliated with Fudan University has recently developed a dedicated large model for diabetes named Diabetica. This model integrates the language processing capabilities of large models with specialized knowledge in diabetes, aiming to provide intelligent support for doctors, patients, and medical education. The team employed a novel framework to establish a comprehensive data processing system, created high-quality datasets and evaluation benchmarks, and fine-tuned the large language model, significantly enhancing its performance on diabetes-related tasks.